ArticleClinics and practice2023

Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Metastatic Lung Adenocarcinoma Patients Receiving Nivolumab Combined with Bevacizumab, Carboplatin and Paclitaxel: Two Case Reports.

Ping-Chih Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.